Discussion on high-priced drugs and whether the prices are sustainable in the long run.
According to a Harvard University/ Politico poll taken after the 2018 elections, American citizens really want Congress to do something -- anything -- about the skyrocketing cost of prescription drugs in this country.
Actually, medicine costs are growing at the slowest rate in years.
Market-based policies the biopharmaceutical industry supports that can lower patients’ drug costs.
The high cost of medicine has damaged the industry's reputation, but price and patient outcomes aren't mutually exclusive.
More than 7,000 medicines are in development globally.